Researchmoz added Most up-to-date research on "Growth Prospects Of Global Testosterone Replacement Therapy Market For 2017-2020" to its huge collection of research reports.
Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.
Technavios analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775689
Key vendors
AbbVie
Allergan
Eli Lilly and Company
Endo Pharmaceuticals
Other prominent vendors
Acerus Pharmaceuticals Corporation
Antares Pharma
Bayer HealthCare Pharmaceuticals
Bedford Labs
Clarus Therapeutics
Ferring Pharmaceuticals
Forendo Pharma
Juniper Pharmaceuticals
Lipocine
MetP Pharma
Market driver
Increase in older population
For a full, detailed list, view our report
Market challenge
FDA warnings on use of testosterone products
For a full, detailed list, view our report
Market trend
Entry of SARMs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775689
Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.
Technavios analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775689
Key vendors
AbbVie
Allergan
Eli Lilly and Company
Endo Pharmaceuticals
Other prominent vendors
Acerus Pharmaceuticals Corporation
Antares Pharma
Bayer HealthCare Pharmaceuticals
Bedford Labs
Clarus Therapeutics
Ferring Pharmaceuticals
Forendo Pharma
Juniper Pharmaceuticals
Lipocine
MetP Pharma
Market driver
Increase in older population
For a full, detailed list, view our report
Market challenge
FDA warnings on use of testosterone products
For a full, detailed list, view our report
Market trend
Entry of SARMs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775689
No comments:
Post a Comment